These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8739115

  • 1. Aspects of the neuroendocrine control of somatotropic function in calorically restricted dogs and patients with eating disorders: studies with cholinergic drugs.
    Müller EE, Rolla M.
    Psychiatry Res; 1996 Apr 16; 62(1):51-63. PubMed ID: 8739115
    [Abstract] [Full Text] [Related]

  • 2. Studies of growth hormone secretion in calorically restricted dogs: effect of cholinergic agonists and antagonists, glucose and thyrotropin-releasing hormone.
    Arce VM, Cella SG, Locatelli V, Müller EE.
    Neuroendocrinology; 1991 May 16; 53(5):467-72. PubMed ID: 1908062
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone responses to growth hormone-releasing hormone and hexarelin in fed and fasted dogs: effect of somatostatin infusion or pretreatment with pirenzepine.
    Rigamonti AE, Marazzi N, Cella SG, Cattaneo L, Müller EE.
    J Endocrinol; 1998 Feb 16; 156(2):341-8. PubMed ID: 9518881
    [Abstract] [Full Text] [Related]

  • 4. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa.
    Ghigo E, Arvat E, Gianotti L, Nicolosi M, Valetto MR, Avagnina S, Bellitti D, Rolla M, Müller EE, Camanni F.
    Biol Psychiatry; 1994 Nov 15; 36(10):689-95. PubMed ID: 7880938
    [Abstract] [Full Text] [Related]

  • 5. Effects of cholinergic muscarinic antagonist pirenzepine on GH response to GHRH 1-40 in patients with anorexia nervosa.
    Rolla M, Andreoni A, Belliti D, Ferdeghini M, Cristofani R, Müller EE.
    Endocrinol Exp; 1990 Mar 15; 24(1-2):195-204. PubMed ID: 2113857
    [Abstract] [Full Text] [Related]

  • 6. Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders.
    Rolla M, Andreoni A, Belliti D, Cristofani R, Ferdeghini M, Müller EE.
    Biol Psychiatry; 1991 Jun 01; 29(11):1079-91. PubMed ID: 1908328
    [Abstract] [Full Text] [Related]

  • 7. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis.
    Díez JJ, Iglesias P, Selgas R, Bajo MA, Aguilera A.
    Clin Endocrinol (Oxf); 2000 Nov 01; 53(5):587-93. PubMed ID: 11106919
    [Abstract] [Full Text] [Related]

  • 8. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L, Rolla M, Arvat E, Belliti D, Valetto MR, Ferdeghini M, Ghigo E, Müller EE.
    Biol Psychiatry; 1999 Feb 01; 45(3):334-9. PubMed ID: 10023511
    [Abstract] [Full Text] [Related]

  • 9. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
    Beccaria L, Marziani E, Manzoni P, Arvat E, Valetto MR, Gianotti L, Ghigo E, Chiumello G.
    Dement Geriatr Cogn Disord; 1998 Feb 01; 9(2):78-81. PubMed ID: 9524798
    [Abstract] [Full Text] [Related]

  • 10. Cholinergic control of growth hormone (GH) responses to GH-releasing hormone in insulin dependent diabetics: evidence for attenuated hypothalamic somatostatinergic tone and decreased GH autofeedback.
    Ismail IS, Scanlon MF, Peters JR.
    Clin Endocrinol (Oxf); 1993 Feb 01; 38(2):149-57. PubMed ID: 8094648
    [Abstract] [Full Text] [Related]

  • 11. Cholinergic modulation of growth hormone-releasing hormone effects on growth hormone secretion in dementia.
    Murialdo G, Zerbi F, Filippi U, Tosca P, Fonzi S, Di Paolo E, Costelli P, Porro S, Polleri A, Savoldi F.
    Neuropsychobiology; 1993 Feb 01; 24(3):129-34. PubMed ID: 1983729
    [Abstract] [Full Text] [Related]

  • 12. Activation of cholinergic neurotransmission by pyridostigmine reverses the inhibitory effect of hyperglycemia on growth hormone (GH) releasing hormone-induced GH secretion in man: does acute hyperglycemia act through hypothalamic release of somatostatin?
    Peñalva A, Burguera B, Casabiell X, Tresguerres JA, Dieguez C, Casanueva FF.
    Neuroendocrinology; 1989 May 01; 49(5):551-4. PubMed ID: 2566942
    [Abstract] [Full Text] [Related]

  • 13. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
    Massara F, Ghigo E, Demislis K, Tangolo D, Mazza E, Locatelli V, Müller EE, Molinatti GM, Camanni F.
    Neuroendocrinology; 1986 May 01; 43(6):670-5. PubMed ID: 3093909
    [Abstract] [Full Text] [Related]

  • 14. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine.
    Valcavi R, Valente F, Dieguez C, Zini M, Procopio M, Portioli I, Ghigo E.
    J Clin Endocrinol Metab; 1993 Sep 01; 77(3):616-20. PubMed ID: 8103770
    [Abstract] [Full Text] [Related]

  • 15. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
    Tamai H, Komaki G, Matsubayashi S, Kobayashi N, Mori K, Nakagawa T, Truong MP, Walter RM, Kumagai LF.
    J Clin Endocrinol Metab; 1990 Mar 01; 70(3):738-41. PubMed ID: 2106528
    [Abstract] [Full Text] [Related]

  • 16. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
    Maccario M, Procopio M, Grottoli S, Oleandri SE, Razzore P, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1995 Dec 01; 80(12):3774-8. PubMed ID: 8530634
    [Abstract] [Full Text] [Related]

  • 17. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
    Peñalva A, Carballo A, Pombo M, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1993 Jan 01; 76(1):168-71. PubMed ID: 8421084
    [Abstract] [Full Text] [Related]

  • 18. Radiation and neuroregulatory control of growth hormone secretion.
    Ogilvy-Stuart AL, Wallace WH, Shalet SM.
    Clin Endocrinol (Oxf); 1994 Aug 01; 41(2):163-8. PubMed ID: 7923820
    [Abstract] [Full Text] [Related]

  • 19. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1990 May 01; 70(5):1361-70. PubMed ID: 2159483
    [Abstract] [Full Text] [Related]

  • 20. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
    Cordido F, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1989 Feb 01; 68(2):290-3. PubMed ID: 2493023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.